[artículo] 
inThe American Journal of Psychiatry > Año 2021 - Vol. 178 - No.5 (Mayo) . - pp. 383-399

Título :	Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression : an international expert opinion on the available evidence and implementation
Tipo de documento:	texto impreso
Autores:	McIntyre, Roger S., Autor ; Rosenblat, Joshua D., Autor ; Charles B. Nemeroff, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 383-399
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Etiquetas:	Ketamina, Esketamina, Depresión resistente al tratamiento, Trastorno depresivo mayor, Trastorno bipolar, Suicidio
Resumen:	Replicated international studies have underscored the human and societal costs associated with major depressive disorder. Despite the proven efficacy of monoamine-based antidepressants in major depression, the majority of treated individuals fail to achieve full syndromal and functional recovery with the index and subsequent pharmacological treatments.
Link:	./index.php?lvl=notice_display&id=26258

[artículo] Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression : an international expert opinion on the available evidence and implementation [texto impreso] / McIntyre, Roger S., Autor ; Rosenblat, Joshua D., Autor ; Charles B. Nemeroff, Autor . - 2021 . - pp. 383-399.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.5 (Mayo) . - pp. 383-399

Etiquetas:	Ketamina, Esketamina, Depresión resistente al tratamiento, Trastorno depresivo mayor, Trastorno bipolar, Suicidio
Resumen:	Replicated international studies have underscored the human and societal costs associated with major depressive disorder. Despite the proven efficacy of monoamine-based antidepressants in major depression, the majority of treated individuals fail to achieve full syndromal and functional recovery with the index and subsequent pharmacological treatments.
Link:	./index.php?lvl=notice_display&id=26258